|
|
| | Anticancer agent 107 Basic information |
| Product Name: | Anticancer agent 107 | | Synonyms: | Anticancer agent 107;1H-Cyclohepta[4,5]thieno[3,2-e]pyrrolo[1,2-a]pyrimidine-3-carbonitrile, 2,4,5,6,7,8,9,10-octahydro-1-[2-(4-methoxyphenyl)-2-oxoethylidene]-2,5-dioxo-, (1E)- | | CAS: | 2397573-96-3 | | MF: | C24H19N3O4S | | MW: | 445.49 | | EINECS: | | | Product Categories: | | | Mol File: | 2397573-96-3.mol |  |
| | Anticancer agent 107 Chemical Properties |
| Melting point | 278-279 °C(Solvent: Acetonitrile) | | Boiling point | 747.245±60.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.482±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 11.105±0.40(predicted) |
| | Anticancer agent 107 Usage And Synthesis |
| Uses | Anticancer agent 107(Compd 11jc) has significant antitumor activity and can be used as an anticancer agent in the study of pulmonary metastatic melanoma[1]. | | References | [1] Anna Rogova, et al. Synthesis of thieno[3,2-e]pyrrolo[1,2-a]pyrimidine derivatives and their precursors containing 2-aminothiophenes fragments as anticancer agents for therapy of pulmonary metastatic melanoma. Eur J Med Chem. 2023 Jun 5;254:115325. DOI:10.1016/j.ejmech.2023.115325 |
| | Anticancer agent 107 Preparation Products And Raw materials |
|